Pediatrix Medical Group, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B | $1.73B | $1.78B | $1.72B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $240.8M | $238.4M | $227.5M | $231.4M | $263.4M | $248.9M | $244.5M | $232.2M |
| Operating Income | $208.8M | $-68.7M | $7.3M | $172.7M | $202.9M | $98.1M | $171.8M | $248.4M |
| Operating Margin | 10.9% | -3.4% | 0.4% | 8.8% | 10.6% | 5.7% | 9.7% | 14.4% |
| Interest Expense | — | — | $42.1M | $39.7M | $68.7M | $110.5M | $118.9M | $92.9M |
| Pretax Income | $216.4M | $-101.3M | $-48.4M | $81.4M | $135.2M | $7.1M | $58.8M | $166.2M |
| Income Tax Expense | $51.0M | $-2.3M | $12.0M | $18.8M | $27.2M | $16.7M | $16.6M | $44.7M |
| Net Income | $165.4M | $-99.1M | $-60.4M | $66.3M | $131.0M | $-796.5M | $-1.50B | $268.6M |
| Net Margin | 8.6% | -4.9% | -3.0% | 3.4% | 6.9% | -45.9% | -84.2% | 15.6% |
| EPS (Basic) | $1.97 | $-1.19 | $-0.73 | $0.79 | $1.54 | $-9.55 | $-17.94 | $2.95 |
| EPS (Diluted) | $1.94 | $-1.19 | $-0.73 | $0.79 | $1.53 | $-9.55 | $-17.83 | $2.93 |
| Shares Outstanding (Basic) | 84.1M | 83.3M | 82.2M | 83.5M | 84.8M | 83.4M | 83.5M | 91.1M |
| Shares Outstanding (Diluted) | 85.3M | 83.3M | 82.2M | 84.1M | 85.8M | 83.4M | 84.0M | 91.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |